SOURCES SOUGHT
J -- Ion Chromatography System Maintenance
- Notice Date
- 4/9/2013
- Notice Type
- Sources Sought
- NAICS
- 811219
— Other Electronic and Precision Equipment Repair and Maintenance
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- 1117105
- Archive Date
- 5/1/2013
- Point of Contact
- Crystal G. McCoskey, Phone: 8705437267
- E-Mail Address
-
crystal.mccoskey@fda.hhs.gov
(crystal.mccoskey@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION This is a sources sought to determine the availability and capability of small businesses to provide technically certified equipment maintenance. The associated North American Industry Classification System (NAICS) Code is‐ 811219 Other Electronic and Precision Equipment Repair and Maintenance; Small Business Size Standard is $19.0 million. Part I: General Information (Introduction/Background/Scope) The U.S. Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research (CBER), Division of Biological Standards and Quality Control's (DBSQC) requirement for service on one (1) Dionex Ion Chromatography System (ICS) 3000. DBSQC serves as a Standards Preparation and Testing laboratory for CBER. DBSQC is also an ISO 17025 accredited testing laboratory of CBER. The Dionex ICS 3000 System is used for testing of ions including carbohydrates in vaccines and other biological substances. This service is critical to the mission of CBER since the testing will be a part of official testing by DBSQC in support licensing, lot release, and other regulatory decisions. Part II: Work Requirements A. Service Requirements Contractor shall: • Perform quarterly on-site preventative maintenance to include all labor, travel, parts, kits, components, subassemblies, etc. • Provide Unlimited On-Site Corrective Maintenance/Repairs inclusive of all labor, travel, parts, components, subassemblies, etc. • Include unlimited trouble-shooting capabilities based on complete knowledge of the entire system, immediate access to certified replacement parts, and immediate access to improvements and new procedures provided by the original equipment manufacturer by phone, email, live-chat Interface, etc. • Provide access to the manufacturer's call center for technical assistance. The call center must be staffed by senior engineers to provide a high level of expertise for troubleshooting the system. • Include instrument qualification services, instrument qualification kits, and repairs necessary for qualification • Provide service by engineers who are trained and certified by the original manufacturer. Engineers shall have access to the manufacturer's latest technical developments, repair procedures, application updates, diagnostic software, and planned maintenance procedures. • Include coverage for unlimited software and firmware updates and maintenance. ICS3000 subassembly list to be maintained: • ICS3 Dual Pump Assembly +DGAS, Serial No. 08050061 • ICS3 EG Assembly, Serial No. 08050924 • ICS3 Dual Detector Compartment Assembly, Serial No. 08050959 • ICS3/5 Analytical Connectivity Detector DET/Cell Assembly, Serial No.08050788 • ICS3/5 Auto Sampler -IV-SP+ST Assembly, Serial No. 08050659 • USB Dongle CM, LC PROD -Features, Serial No. 58037 • ED Electochemical Detector (without Cell), Serial No. 08050631 B. Records and Reports: The Contractor shall, commensurate with the completion of each service call (inclusive of warranty service), provide the end-user of the equipment with a copy of a field service report/ticket identifying the equipment name, manufacturer, model number, and serial number of the equipment being serviced/repaired and detailing the reason for the service call, a detailed description of the work performed, the test instruments or other equipment used to affect the repair or otherwise perform the service, the name(s) and contact information of the technician who performed the repair/service, and for information purposes, the on-site hours expended and parts/components replaced. In addition, the Contractor shall provide a written report to the FDA COR and Contract Specialist, summarizing all maintenance and repair activities (including warranty work) each time service and/or repair is performed. Part III: Supporting Information A. Place of Performance Shall be maintained at: Nicholson Lane Research Center (NLRC) 5516 Nicholson Lane Bldg B, Room 2349 Rockville, MD 20895 Vendor shall coordinate all maintenance with Project Officer. Technicians are required to use NLRC parking lot and report to the guards at Bldg B. The guards will contact the Project Officer to escort the technicians in the FDA facility. B. Period of Performance 5/1/2013 - 4/30/2014 - Base 5/1/2014 - 04/30/2015 - Option Period 1 5/1/2015 - 04/30/2016 - Option Period 2 5/1/2016 - 04/30/2017 - Option Period 3 5/1/2017 - 04/30/2018 - Option Period 4 Part III: Instructions to Prospective Respondents Responses to this sources sought shall unequivocally demonstrate that respondent has Original Equipment Manufacturer (OEM) certified technicians to perform the services. Though the target audience is small businesses capable of servicing the equipment, all interested parties may respond. At a minimum, responses shall include the following: • Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; • Three (3) years of past performance information for the service of same or substantially similar items, to include date of services, description (should also include technical literature and specifications), dollar value, client name, client address, client point of contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent; • Descriptive literature, brochures, specifications, marketing material, etc. detailing the nature of the services the responding firm is regularly engaged in providing; • If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; • If a large business, identify the subcontracting opportunities that would exist for small business concerns; • Although this is not a request for quote, informational pricing is encouraged; • The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested Parties must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before April 16, 2013 by 1:00 PM (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, OC/OA/OAGS, Attn: Crystal G. McCoskey, 3900 NCTR Road, Bldg 50/Room 426, HFT‐320, Jefferson, AR 72079‐9502 or email crystal.mccoskey@fda.hhs.gov. Reference #1117105 in all correspondence with the point of contact listed above. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether this requirement should be set aside for small business, made available to full and open competition or procured through other than full and open acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a combined synopsis/solicitation (No. 1117105) may be published via FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/1117105/listing.html)
- Record
- SN03031891-W 20130411/130409234349-33b70b2d17a202a4270fc11b6cf2a033 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |